The fight against Tuberculosis (TB) remains a critical global health challenge. Despite advancements in healthcare, early diagnosis remains a hurdle. This article aims to explore the contemporary diagnostic approaches available in healthcare today.
The conventional method for TB diagnosis is the sputum smear microscopy. It is cost-effective and provides rapid results. However, its sensitivity is limited, especially in HIV co-infected patients and children. The Culture method, although more sensitive, is time-consuming and requires sophisticated laboratories, limiting its use in resource-limited settings.
GeneXpert MTB/RIF, a real-time polymerase chain reaction (PCR) based test, has revolutionized TB diagnosis. It provides results within hours and has high sensitivity and specificity. It also detects rifampicin resistance, aiding in the management of drug-resistant TB. Nevertheless, its high cost and need for regular calibration make it less feasible for low-income countries.
Tuberculin skin test (TST) and Interferon Gamma Release Assays (IGRAs) are immunological tests used to detect latent TB infection. TST is inexpensive and easy to perform but has low specificity in BCG-vaccinated individuals. IGRAs, although more specific, are expensive and require a well-equipped laboratory.
Radiology plays a crucial role in TB diagnosis. Chest radiography can detect pulmonary TB, while CT and MRI are useful in diagnosing extrapulmonary TB. However, imaging cannot confirm TB and needs to be complemented by microbiological or histological confirmation.
In conclusion, while significant strides have been made in TB diagnosis, challenges persist. The ideal diagnostic tool should be sensitive, specific, rapid, affordable, and easy to use. Hence, there is a pressing need for continuous research and innovation to develop such a tool, especially for use in resource-limited settings.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation